Miracle Mile Advisors LLC Has $590,000 Holdings in Intuitive Surgical, Inc. (NASDAQ:ISRG)

Miracle Mile Advisors LLC lifted its holdings in Intuitive Surgical, Inc. (NASDAQ:ISRG) by 2.8% during the 1st quarter, according to its most recent disclosure with the SEC. The institutional investor owned 1,478 shares of the medical equipment provider’s stock after acquiring an additional 40 shares during the period. Miracle Mile Advisors LLC’s holdings in Intuitive Surgical were worth $590,000 as of its most recent filing with the SEC.

Other institutional investors and hedge funds have also modified their holdings of the company. Baystate Wealth Management LLC grew its stake in shares of Intuitive Surgical by 150.0% in the fourth quarter. Baystate Wealth Management LLC now owns 75 shares of the medical equipment provider’s stock valued at $25,000 after acquiring an additional 45 shares in the last quarter. MCF Advisors LLC grew its stake in Intuitive Surgical by 108.1% during the fourth quarter. MCF Advisors LLC now owns 77 shares of the medical equipment provider’s stock worth $26,000 after buying an additional 40 shares in the last quarter. Able Wealth Management LLC acquired a new stake in Intuitive Surgical during the fourth quarter worth about $28,000. Atticus Wealth Management LLC grew its stake in Intuitive Surgical by 85.4% during the fourth quarter. Atticus Wealth Management LLC now owns 89 shares of the medical equipment provider’s stock worth $30,000 after buying an additional 41 shares in the last quarter. Finally, MeadowBrook Investment Advisors LLC acquired a new stake in Intuitive Surgical during the fourth quarter worth about $30,000. 83.64% of the stock is currently owned by institutional investors and hedge funds.

Wall Street Analysts Forecast Growth

A number of brokerages have issued reports on ISRG. Stifel Nicolaus increased their price objective on shares of Intuitive Surgical from $420.00 to $430.00 and gave the stock a “buy” rating in a research note on Monday, April 8th. BTIG Research increased their price objective on shares of Intuitive Surgical from $412.00 to $421.00 and gave the stock a “buy” rating in a research note on Friday, April 19th. Jefferies Financial Group increased their price objective on shares of Intuitive Surgical from $365.00 to $375.00 and gave the stock a “hold” rating in a research note on Friday, April 19th. Robert W. Baird reduced their price objective on shares of Intuitive Surgical from $440.00 to $436.00 and set an “outperform” rating on the stock in a research note on Friday, April 19th. Finally, The Goldman Sachs Group initiated coverage on shares of Intuitive Surgical in a report on Thursday, May 30th. They issued a “buy” rating and a $500.00 target price for the company. Five equities research analysts have rated the stock with a hold rating and fourteen have given a buy rating to the company’s stock. According to data from MarketBeat.com, Intuitive Surgical currently has an average rating of “Moderate Buy” and a consensus target price of $403.67.

Insiders Place Their Bets

In other Intuitive Surgical news, Director Craig H. Barratt sold 1,400 shares of the firm’s stock in a transaction that occurred on Wednesday, June 12th. The shares were sold at an average price of $421.06, for a total transaction of $589,484.00. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this hyperlink. In other Intuitive Surgical news, Director Craig H. Barratt sold 1,400 shares of the firm’s stock in a transaction that occurred on Wednesday, June 12th. The shares were sold at an average price of $421.06, for a total transaction of $589,484.00. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this hyperlink. Also, EVP Myriam Curet sold 5,318 shares of the firm’s stock in a transaction that occurred on Tuesday, April 23rd. The stock was sold at an average price of $370.66, for a total transaction of $1,971,169.88. Following the transaction, the executive vice president now owns 298 shares of the company’s stock, valued at approximately $110,456.68. The disclosure for this sale can be found here. In the last 90 days, insiders sold 17,956 shares of company stock worth $6,927,011. 0.90% of the stock is currently owned by insiders.

Intuitive Surgical Price Performance

Shares of NASDAQ ISRG opened at $436.24 on Tuesday. The company has a 50 day simple moving average of $403.83 and a 200 day simple moving average of $383.50. The firm has a market cap of $154.73 billion, a PE ratio of 78.74, a price-to-earnings-growth ratio of 5.75 and a beta of 1.39. Intuitive Surgical, Inc. has a 1 year low of $254.85 and a 1 year high of $448.10.

Intuitive Surgical (NASDAQ:ISRG) last issued its quarterly earnings data on Thursday, April 18th. The medical equipment provider reported $1.50 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $1.40 by $0.10. Intuitive Surgical had a net margin of 27.16% and a return on equity of 12.91%. The business had revenue of $1.89 billion during the quarter, compared to analyst estimates of $1.87 billion. During the same quarter last year, the business earned $1.00 EPS. The firm’s quarterly revenue was up 11.5% on a year-over-year basis. As a group, research analysts anticipate that Intuitive Surgical, Inc. will post 4.8 earnings per share for the current fiscal year.

About Intuitive Surgical

Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.